MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
23
Beneficiaries
—
Total drug cost
$46K
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Imatinib Mesylate23 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE